Results 151 to 160 of about 9,834 (169)

Exploring the Self-Reported Motivations of Kratom (Mitragyna speciosa Korth.) Use: A Cross-Sectional Investigation

American Journal of Drug and Alcohol Abuse, 2022
Ornella Corazza, Charles A Veltri, Marc T. Swogger   +2 more
exaly  

Assessing the Therapeutic Potential and Toxicity of Mitragyna speciosa in Opioid Use Disorder

Expert Opinion on Drug Metabolism and Toxicology, 2021
Christopher R McCurdy, Abhisheak Sharma
exaly  

Development of a Physiologically Based Pharmacokinetic Model of Mitragynine, Psychoactive Alkaloid in Kratom (Mitragyna speciosa Korth.), in Rats and Humans

Journal of Psychoactive Drugs, 2021
Janthima Methaneethorn, Tran Quoc Ba, Winai Wananukul   +2 more
exaly  

Prevalence and Description of Kratom (Mitragyna speciosa) Use in the United States: A Cross-Sectional Study

Addiction, 2021
Elise Amioka, Janetta L Iwanicki
exaly  

The Use of Benzodiazepines Among Kratom (Mitragyna speciosa Korth.) Users

Journal of Psychoactive Drugs, 2020
Edward W Boyer, Darshan Singh, Suresh Narayanan   +2 more
exaly  

Mitragyna speciosa

Reactions Weekly, 2020
openaire   +2 more sources

Factor Analytical Investigation of Krathom (Mitragyna speciosa Korth.) Withdrawal Syndrome in Thailand

Journal of Psychoactive Drugs, 2016
Alan Geater, Sawitri Assanangkornchai, Darika Saingam   +2 more
exaly  

Acute Toxicity Study of the Standardized Methanolic Extract of Mitragyna speciosa Korth in Rodent

Journal of Ethnopharmacology, 2010
Jafri M. Abdullah
exaly  

Severity of Pain and Sleep Problems During Kratom (Mitragyna speciosa Korth.) Cessation Among Regular Kratom Users

Journal of Psychoactive Drugs, 2018
Hadzliana Zainal, Sabariah N Harun, Darshan Singh   +2 more
exaly  

Phytochemical Characterization of the Leaves of Mitragyna speciosa Grown in USA

Natural Product Communications, 2009
Christopher R McCurdy, Francisco León, Stephen J Cutler   +2 more
exaly